Comparing Exposure v Imagery Rescripting in People With OCD: a SCED

NCT ID: NCT06944366

Last Updated: 2025-04-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-30

Study Completion Date

2025-05-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Individuals with OCD may experience intrusive future orientated thoughts and images, which are extremely distressing and interfering in life. This project aims to explore whether imagery rescripting or exposure may be a more effective intervention for individuals with OCD experiencing such images.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obsessive-Compulsive Disorder (OCD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ImR

ImR completed as first intervention then ImExp

Group Type EXPERIMENTAL

Imagery intervention

Intervention Type OTHER

Imagery rescripting or imaginal exposure

ImExp

ImExp completed then ImR

Group Type EXPERIMENTAL

Imagery intervention

Intervention Type OTHER

Imagery rescripting or imaginal exposure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Imagery intervention

Imagery rescripting or imaginal exposure

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or over
* Main diagnosis of OCD (assessed by the Structured Clinical Interview for ICD11)
* Must report future orientated images that are distressing and ego-dystonic

Exclusion Criteria

* Psychosis, bipolar disorder, or trauma disorder
* Current stimulant or hallucinogenic misuse, alcohol or substance misuse or dependence
* Intellectual disability, dementia, serious cognitive impairment, or organic brain disorder
* Personality Disorder as the main problem
* Active suicidality
* Concurrent engagement in other psychotherapy
* A patient may be taking anti-depressant medication so long as the dose has been stable for 6 weeks and there is no plan to increase the dose.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King's College London

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre for Anxiety Disorders and Trauma

London, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Talana Adams

Role: CONTACT

+44 20 7848 0002

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Talana Adams

Role: primary

+44 20 7848 0002

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRAS Project ID: 342003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.